Tag: Product Recalls

FDA: Class I recall of Zimmer Biomet implantable spinal fusion stimulators

Editor's Note The Food and Drug Administration (FDA) on May 30 identified the recall by Zimmer Biomet (Warsaw, Indiana) of its SpF PLUS-Mini and SpF XL IIB implantable spinal fusion stimulators as Class I, the most serious. The recall was initiated because of higher than allowed levels of potential harmful…

Read More

By: Judy Mathias
May 31, 2017
Share

FDA: Class I recall of HeartMate II LVAS Pocket System Controller

Editor's Note The Food and Drug Administration (FDA) on May 23 identified the recall by Abbott-Thoratec (Pleasanton, California) of its HeartMate II Left Ventricular Assist (LVAS) Pocket System Controller as Class I, the most serious. Abbott-Thoratec has receives 70 reports of incidents in which the controller malfunctions after an exchange,…

Read More

By: Judy Mathias
May 24, 2017
Share

FDA: Class I recall of Wingman35 Crossing Catheters

Editor's Note The Food and Drug Administration on May 17 identified the recall by ReFlow Medical (San Clemente, California) of certain lots of its Wingman35 Crossing Catheters as Class I, the most serious. The catheters are being recalled because of tip splitting or separation that has resulted in two adverse…

Read More

By: Judy Mathias
May 23, 2017
Share

FDA: Abbott recalls coronary catheters

Editor's Note The Food and Drug Administration on May 16 announced the recall by Abbott of specific lots of three coronary dilation and balloon catheters: NC Trek RX Coronary Dilation Catheter NC Traveler Coronary Dilation Catheter NC Tenku RX PTCA Balloon Catheter. The affected lots were manufactured between January 2015…

Read More

By: Judy Mathias
May 19, 2017
Share

FDA: HeartWare VAD splice kit recalled

Editor's Note The Food and Drug Administration (FDA) on May 5 announced that Medtronic is recalling its splice kit used to repair the driveline of the HeartWare Ventricular Assist Device (VAD). The kit was recalled because of a design problem that prevents the repaired cable assembly from withstanding excessive force…

Read More

By: Judy Mathias
May 8, 2017
Share

FDA: Safety alert for Medtronic’s NavLock Tracker

Editor's Note The Food and Drug Administration (FDA) on May 3 issued a Safety Alert for Medtronic’s NavLock Tracker. Medtronic has received 196 medical device reports that included two patient deaths after procedures in which non-Medtronic instruments were used with the NavLock Tracker. The NavLock Tracker enables navigation of Medtronic…

Read More

By: Judy Mathias
May 3, 2017
Share

FDA: Class I recall of Medtronic HVAD controllers, DC adapters

Editor's Note The Food and Drug Administration (FDA) on April 18 designated the recall by Medtronic of its HVAD (HeartWare [left] ventricular assist device) system controllers and DC adapters as Class I, the most serious. Medtronic is issuing an updated controller and has begun to remove current HVAD controllers. The…

Read More

By: Judy Mathias
May 2, 2017
Share

FDA: Hospira recalls 25% Dextrose Injection

Editor's Note The Food and Drug Administration (FDA) on April 24 announced the recall by Hospira (Lake Forest, Illinois) of one lot of 25% Dextrose Injection, USP, (infant) prefilled syringes because of the presence of particulate matter identified as human hair. The affected lot is NDC: 0409-1775-10, Lot 58382EV, Expiry…

Read More

By: Judy Mathias
April 25, 2017
Share

FDA: Recall of Isomeric sterile compounded products

Editor's Note The Food and Drug Administration (FDA) on April 6 announced the recall of all lots of sterile products compounded and packaged by Isomeric Pharmacy Solutions (Salt Lake City, Utah). The recall was issued because of FDA concerns of a lack of sterility assurance, which were brought to Isomeric’s…

Read More

By: Judy Mathias
April 11, 2017
Share

FDA: Recall of Medtronic’s StrataMR adjustable valves and shunts

Editor's Note The Food and Drug Administration (FDA) on April 8 announced the recall of all StrataMR adjustable valves and shunts manufactured by Medtronic (Dublin, Ireland). The recall was issued because of a postimplantation problem that can lead to under-drainage of cerebrospinal fluid, which can lead to headaches, nausea, vomiting,…

Read More

By: Judy Mathias
April 11, 2017
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat